| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
phenotype | 0.400 | None | 0.959 | 2 | 0 | 1990 | 2020 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
phenotype | 0.400 | None | 0.920 | 1 | 0 | 1994 | 2019 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
phenotype | 0.400 | None | 0.924 | 1 | 0 | 2003 | 2020 | ||||||||
|
nuclear factor, erythroid 2 like 2 | 0.357 | 0.885 | 3.6E-03 |
|
phenotype | 0.400 | None | 0.975 | 1 | 0 | 2005 | 2020 | ||||||||
|
microRNA 203a | 0.471 | 0.808 |
|
phenotype | 0.400 | None | 1.000 | 1 | 0 | 2013 | 2019 | |||||||||
|
microRNA 143 | 0.462 | 0.885 |
|
phenotype | 0.400 | None | 1.000 | 1 | 0 | 2006 | 2019 | |||||||||
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
phenotype | 0.400 | None | 0.900 | 1 | 0 | 1993 | 2019 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
phenotype | 0.400 | None | 0.971 | 1 | 0 | 1989 | 2020 | ||||||||
|
caveolin 1 | 0.388 | 0.885 | 8.3E-03 |
|
phenotype | 0.400 | None | 0.979 | 1 | 0 | 2002 | 2019 | ||||||||
|
cut like homeobox 1 | 0.465 | 0.846 | 1.00 |
|
phenotype | 0.370 | None | 0.857 | 1 | 0 | 2002 | 2018 | ||||||||
|
platelet activating factor acetylhydrolase 1b regulatory subunit 1 | 0.504 | 0.769 | 1.00 |
|
phenotype | 0.330 | None | 1.000 | 1 | 0 | 2012 | 2017 | ||||||||
|
small nucleolar RNA, C/D box 50A |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2016 | 2016 | |||||||||||
|
small nucleolar RNA, C/D box 50B |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2016 | 2016 |